- Report
- March 2024
- 183 Pages
Global
From €3251EUR$3,374USD£2,797GBP
€3612EUR$3,749USD£3,107GBP
- Report
- May 2024
- 188 Pages
Global
From €5252EUR$5,450USD£4,517GBP
- Report
- January 2024
- 175 Pages
Global
From €4818EUR$5,000USD£4,144GBP
- Report
- February 2024
- 127 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- April 2023
- 120 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- October 2018
- 88 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- June 2022
- 38 Pages
Global
From €3850EUR$3,995USD£3,311GBP
- Report
- April 2018
- 100 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- January 2018
- 120 Pages
Global
From €577EUR$599USD£496GBP
- Book
- September 2022
- 480 Pages
- Book
- July 2022
- 880 Pages
- Book
- December 2019
- 432 Pages
- Book
- December 2019
- 432 Pages
- Book
- April 2019
- 328 Pages
- Book
- January 2018
- 144 Pages
- Book
- April 2009
- 120 Pages
Ischemia is a medical condition in which there is an inadequate supply of blood to an organ or tissue, usually due to a narrowing of the arteries. In cardiology, ischemia is a major concern, as it can lead to a variety of serious health issues, including heart attack, stroke, and even death. Ischemia can be caused by a variety of factors, including high cholesterol, high blood pressure, smoking, and diabetes. Treatment for ischemia typically involves lifestyle changes, such as diet and exercise, as well as medications and, in some cases, surgery.
There are a number of companies in the ischemia market, including pharmaceutical companies that develop and manufacture medications to treat ischemia, medical device companies that produce devices to diagnose and monitor ischemia, and biotechnology companies that develop treatments for ischemia. Examples of these companies include Pfizer, Medtronic, and Amgen. Show Less Read more